Clinical Trials
1
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Airway Responsiveness in Patients With AECOPD Mechanical Ventilation by Inspiratory and Bronchial Dilation Testchronic Obstructive Pulmonary Disease
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2015-10-30
- Lead Sponsor
- snow
- Target Recruit Count
- 120
- Registration Number
- NCT02592122
- Locations
- 🇨🇳
Department of respiratory and critical care medicine,Beijing Chao-yang Hospital, Beijing, Beijing, China
News
Clinical ink Launches TrialLens: AI-Powered Analytics Dashboard Transforms Clinical Trial Data Management
Clinical ink has introduced TrialLens, an AI-powered analytics dashboard that provides real-time insights into clinical trial operations, subject behavior, and digital biomarker metrics.
Ingenix Secures €9M Seed Funding to Revolutionize Clinical Trials with AI Simulation
• Polish biotech startup Ingenix has raised €9 million in seed funding to develop an AI-powered platform that simulates clinical drug trials from molecular to population levels. • Founded by former Applica executives Piotr Surma and Adam Dancewicz, Ingenix aims to address the 90% failure rate of pilot drugs despite the pharmaceutical industry's $50 billion annual investment in clinical trials. • The funding round was led by Inovo.vc with participation from OTB Ventures and the International Finance Corporation, positioning Ingenix to potentially deliver the pharmaceutical industry's "GPT moment."